There are only two commonly upregulated RBPs including DNMT3B and NYNRIN out of 18 and 8 upregulated RBPs in high‐risk adult and pediatric AML, further indicating the differences in regulatory mechanisms. This evidence concerns the gene DNMT3B and acute myeloid leukemia.